PT  - JOURNAL ARTICLE
AU  - Stefan Rentas
AU  - Komal S. Rathi
AU  - Maninder Kaur
AU  - Pichai Raman
AU  - Ian D. Krantz
AU  - Mahdi Sarmady
AU  - Ahmad Abou Tayoun
TI  - Diagnosing Cornelia de Lange syndrome and related neurodevelopmental disorders using RNA-sequencing
AID  - 10.1101/19008300
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19008300
4099  - http://medrxiv.org/content/early/2019/10/08/19008300.short
4100  - http://medrxiv.org/content/early/2019/10/08/19008300.full
AB  - Purpose Neurodevelopmental phenotypes represent major indications for children undergoing clinical exome sequencing. However, 50% of cases remain undiagnosed even upon exome reanalysis. Here we show RNA sequencing (RNA-seq) on human B lymphoblastoid cell lines (LCL) is highly suitable for neurodevelopmental Mendelian gene testing and demonstrate the utility of this approach in suspected cases of Cornelia de Lange syndrome (CdLS).Methods Genotype-Tissue Expression project transcriptome data for LCL, blood, and brain was assessed for neurodevelopmental Mendelian gene expression. Detection of abnormal splicing and pathogenic variants in these genes was performed with a novel RNA-seq diagnostic pipeline and using a validation CdLS-LCL cohort (n=10) and test cohort of patients who carry a clinical diagnosis of CdLS but negative genetic testing (n=5).Results LCLs share isoform diversity of brain tissue for a large subset of neurodevelopmental genes and express 1.8-fold more of these genes compared to blood (LCL, n=1706; whole blood, n=917). This enables testing of over 1000 genetic syndromes. The RNA-seq pipeline had 90% sensitivity for detecting pathogenic events and revealed novel diagnoses such as abnormal splice products in NIPBL and pathogenic coding variants in BRD4 and ANKRD11.Conclusion The LCL transcriptome enables robust frontline and/or reflexive diagnostic testing for neurodevelopmental disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInternal CHOP departmental fundingAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll data can be available upon request